Allergan Patents definition

Allergan Patents means, to the extent useful for the purposes of the Collaboration and any subsequent commercialization of ACADIA Products, all foreign and domestic: (a) patents issued during the Term; and (b) patents issuing from patent applications that are pending during the Term (including provisionals, divisionals, continuations and continuations-in-part of such applications); and (c) substitutions, extensions, reissues, renewals and inventors certificates relating to the foregoing patents, in each case, which pertain to any of the Collaboration Target/Chemistries and are Controlled by Allergan.
Allergan Patents means any patents solely owned by Allergan pursuant to Section 9.1 hereof.
Allergan Patents means, to the extent useful for purposes of the Collaboration, all foreign and domestic: (a) patents issued or existing as of the Effective Date or during the Research Term which Allergan or its Affiliates owns or controls or to which Allergan or its Affiliates has a license (with the right to sublicense); and (b) patents issuing from patent applications that are pending as of the Effective Date or during the Research Term (including provisionals, divisionals, continuations and continuations-in-part of such applications) which Allergan or its Affiliate owns or controls or to which Allergan or its Affiliates has a license (with the right to sublicense); and (c) substitutions, extensions, reissues, renewals and inventors certificates relating to the foregoing patents, which Allergan or its Affiliates owns or controls or to which Allergan or its Affiliates has a license (with the right to sublicense).

Examples of Allergan Patents in a sentence

  • In the event any alleged or threatened infringement of any patent included in the Allergan Patents, ACADIA Patents or Collaboration Patents by a Third Party cannot be terminated without litigation, the provisions of Section 10.4(b) or (c), as applicable, and Section 10.4(d) shall apply.

  • The Assistant Director (Governance) agreed it needed to be clear, although stated there needed to be balance on how many enquires councillors received direct and what issues could be resolved through other services within the Council.

  • It is aware of no action, suit or inquiry or investigation instituted by or before any court or governmental agency which questions or threatens the validity of this Agreement or of any Allergan Patents and ACADIA Patents.

  • It is aware of no action, suit or inquiry or investigation instituted by or before any court or governmental agency which questions or threatens the validity of this Agreement or of any Allergan Patents or ACADIA Patents.

  • During the Term, Allergan will provide ACADIA with reasonable technical assistance relating to the use of such Allergan Know-How and the practice of such Allergan Patents solely to the extent permitted under the license granted to ACADIA herein.


More Definitions of Allergan Patents

Allergan Patents means any United States patent application including any division, continuation, or continuation-in-part thereof and any foreign patent application or equivalent corresponding thereto and any Letters Patent or the equivalent thereof issuing thereon or reissue, reexamination or extension thereof; which is owned by or licensed to ALLERGAN and in and to which ALLERGAN has a transferable interest during the COLLABORATION TERM insofar as it contains one or more claims to ALLERGAN TECHNOLOGY.
Allergan Patents. 2 1.5. "Allergan Technology" 2 1.6. "Availability Period" 2 1.7. "CNSI Compounds" 2 1.8. "CNSI Patent Rights" 2 1.9. "CNSI Technology" 3 1.10. "Collaboration Compound" 3 1.11. "Development Compound" 3 1.12. "Development Phase" 3 1.13. "Effective Date" 3 1.14. "Excluded Compound" 3 1.15. "Europe" 3 1.16. "Field" 3 1.17. "First Commercial Sale" 3 1.18. "FDA" 4 1.19. "IND" 4 1.20. "Joint Inventions" 4 1.21. "Joint Patent Rights" 4 1.22. "Major Market Country" 4 1.23. "NDA" 4 1.24. "Net Sales" 4 1.25. "Other Countries" 5 1.26. "Party" 5 1.27. "Pivotal Trial" 5 1.28. "Product" 5 1.29. "Program" 5 1.30. "Research Management Committee" 5 1.31. "Research Phase" 5 1.32. "Research Plan" 5 1.33. "Research Program" 5 1.34. "Research Year" 5 1.35. "Third Party" 5 1.36. "Valid Patent Claim" 5 1.37. "Validated Target" 6
Allergan Patents means to the extent useful in the Program all foreign and domestic: (a) patents issued or existing as of the Effective Date; and (b) patents issuing from patent applications that are pending as of the Effective Date (including provisionals, divisionals, continuations and continuations-in-part of such applications); (c) patent applications filed after the Effective Date and patents issuing therefrom (including originals, provisionals, divisionals, continuations and continuations-in-part of such applications); and (d) substitutions, extensions, reissues, renewals and inventors certificates relating to the foregoing patents, which Allergan owns, controls or to which Allergan has a license (with the right to sublicense).
Allergan Patents means Allergan CDP Patents and Allergan’s ownership interest in Joint CDP Patents.
Allergan Patents means, with respect to a Product, the Patents listed on Schedule 1.11 and any other Allergan Licensed NexMed Patents.
Allergan Patents means, to the extent useful in the Collaboration Field, all foreign and domestic: (a) patents issued or existing as of the Effective Date; and (b) patents issuing from patent applications that are pending as of the Effective Date (including provisionals, divisionals, continuations and continuations-in-part of such applications); and (c) substitutions, extensions, reissues, renewals and inventors certificates relating to the foregoing patents, which Allergan owns or controls or to which Allergan has a license (with the right to sublicense).
Allergan Patents means the patents and patent applications set forth on Exhibit 1.5, and any other patents or patent applications, in any country in the Restasis(TM) Territory owned by or exclusively licensed to Allergan during the term of this Agreement that relate to Restasis(TM) in the Field, together with any patents that may issue therefor in the Restasis(TM) Territory, including any and all extensions, renewals, continuations, continuations-in-part, divisions, patents-of-additions, reissues, supplementary protection certificates or foreign counterparts of any of the foregoing.